Increasing evidence has suggested that CSCs contribute to acquired resistance to chemotherapy [29]; moreover, others have shown that the metastatic, aggressive behavior of IBC is mediated by a CSC component that displays ALDH enzymatic activity [11]. Here, LDHA is linked to inflammatory breast carcinoma.